Our findings demonstrate that suppression of the TBX2 subfamily occurs early on in human NSCLC pathogenesis and exhibits diagnostic properties of a candidate high-potential biomarker for early detection of lung cancer in high-risk smokers. The gene discussed is TBX2; the disease is lung carcinoma.